Literature DB >> 10748011

Design of potent beta-lactamase inhibitors by phage display of beta-lactamase inhibitory protein.

W Huang1, Z Zhang, T Palzkill.   

Abstract

Beta-lactamase inhibitory protein (BLIP) binds tightly to several beta-lactamases including TEM-1 beta-lactamase (K(i) 0.1 nm). The TEM-1 beta-lactamase/BLIP co-crystal structure indicates that two turn regions in BLIP insert into the active site of beta-lactamase to block the binding of beta-lactam antibiotics. Residues from each turn, Asp(49) and Phe(142), mimic interactions made by penicillin G when bound in the beta-lactamase active site. Phage display was used to determine which residues within the turn regions of BLIP are critical for binding TEM-1 beta-lactamase. The sequences of a set of functional mutants from each library indicated that a few sequence types were predominant. These BLIP mutants exhibited K(i) values for beta-lactamase inhibition ranging from 0.01 to 0.2 nm. The results indicate that even though BLIP is a potent inhibitor of TEM-1 beta-lactamase, the wild-type sequence of the active site binding region is not optimal and that derivatives of BLIP that bind beta-lactamase extremely tightly can be obtained. Importantly, all of the tight binding BLIP mutants have sequences that would be predicted theoretically to form turn structures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748011     DOI: 10.1074/jbc.M001285200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.

Authors:  I C Materon; T Palzkill
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Protein-protein docking with multiple residue conformations and residue substitutions.

Authors:  David M Lorber; Maria K Udo; Brian K Shoichet
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

Review 3.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

4.  Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Banumathi Sankaran; Peter Zwart; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

5.  Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions.

Authors:  Bartlomiej G Fryszczyn; Nicholas G Brown; Wanzhi Huang; Miriam A Balderas; Timothy Palzkill
Journal:  Protein Eng Des Sel       Date:  2011-09-06       Impact factor: 1.650

6.  Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase.

Authors:  Ji Yuan; Dar-Chone Chow; Wanzhi Huang; Timothy Palzkill
Journal:  J Mol Biol       Date:  2011-01-13       Impact factor: 5.469

7.  Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.

Authors:  K E Conrath; M Lauwereys; M Galleni; A Matagne; J M Frère; J Kinne; L Wyns; S Muyldermans
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

8.  Structural insight into the kinetics and DeltaCp of interactions between TEM-1 beta-lactamase and beta-lactamase inhibitory protein (BLIP).

Authors:  Jihong Wang; Timothy Palzkill; Dar-Chone Chow
Journal:  J Biol Chem       Date:  2008-10-07       Impact factor: 5.157

9.  Efficient production of secretory Streptomyces clavuligerus β-lactamase inhibitory protein (BLIP) in Pichia pastoris.

Authors:  Kin-Ho Law; Man-Wah Tsang; Yuk-Ki Wong; Ming-San Tsang; Pui-Yee Lau; Kwok-Yin Wong; Kwok-Ping Ho; Yun-Chung Leung
Journal:  AMB Express       Date:  2018-04-20       Impact factor: 3.298

10.  Emerging Applications of Bacterial Spores in Nanobiotechnology.

Authors:  Ezio Ricca; Simon M Cutting
Journal:  J Nanobiotechnology       Date:  2003-12-15       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.